.
Feedback

Pacifica City Council Candidates Get to the Issues

Candidate forum hosted by the chamber of commerce last week addresses key issues facing Pacifica. Where do you stand?

A week ago the Pacifica Chamber of Commerce hosted a candidate forum in the City Council Chambers to highlight the positions held by Pacifica City Council candidates on key issues facing the community.

City Council candidates for the 4-year term — Karen Ervin, Mary Ann Nihart and Susan Vellone — and council candidates for the 2 year term — Richard Campbell, Gary Mondfrans, Mike O'Neill, and Victor Spano — were all invited to participate.

Long-time Pacifica resident Connie Menefee moderated the session, asking the candidations four questions concerning Pacifica's grim economic outlook, infrastructure issues, highway widening and development plans, and different approaches toward fixing some of Pacifica's challenges.

Those four questions were drafted by Pacifica resident and chair of the Government Affairs Committee of the Pacifica Chamber of Commerce, Jim Wagner, who used some help with the questions from other Government Affairs Committee members.

Those four questions were:

• What are your thoughts on the development of the Palmetto Main Street and the new library, and would you advocate the plans to the California Coastal Commission?

• Do you support Highway 1 improvement? If not, what is your proposal to alleviate gridlock and provide emergency vehicle access?

• What innovations would you propose to increase Pacifica's business base and how would you strengthen the local economy?

• What issue makes you stand out?

A full report of the candidate’s repsonses to these forum questions can be read here in a recent Pacifica Tribune article.

Or to read more candidate questions drafted by Wagner on the Pacifica Chamber of Commerce website, and the candidate's responses to those questions, go here.

From Highway 1 widening and the future of the Sharp Park Golf Course to the Palmetto "Main Street" plans and expanding Pacifica's tax base, what issues are important to you? Where do you stand on Pacificia's economic outlook and fixing Pacifica's challenges?

Follow Pacifica Patch on Twitter | Like us on Facebook | Sign up for our daily newsletter Blog for us

Newsletter & Alerts

Get the best stories each day and important breaking news

Subscribe

Not from Pacifica Patch? Find your Local Patch »

Loading comments ...
Note Article
Just a short thought to get the word out quickly about anything in your neighborhood.
Share something with your neighbors. Write a new post... What's up? Make an announcement, speak your mind, or sell something
Hnin May 24, 2013 at 06:31 pm
Please help share it on your facebook as well. Anything to find our cat.Read More http://sfbay.craigslist.org/pen/laf/3825190526.html
Janet Arline Barker May 17, 2013 at 11:18 am
Awesome! Next Tuesday, Thursday or Friday are open. Name a time and place. I used to write 3Read More different columns for San Bruno, Millbrae, and Burlingame Patch. I am ready to write for Pacifica Patch & blog too. Here's my personal blog...I do sporadically. Www.art-Janet.blogspot.com My art studio is at Sanchez Art Center #11
Christa Bigue (Editor) May 17, 2013 at 11:05 am
When can we meet for coffee Janet? Since you're the first one to post in our biz update section youRead More get to have coffee and chat with your local Patch editor! Email me at christa.bigue@patch.com and we'll find a date and place.
Anon. April 14, 2013 at 01:43 am
I can start with the comments on the Theravance drug, fluticasone fluroate - the active moiety inRead More this compound is the same, fluticasone (proprionate) that has been marketed by GSK for the same indication for approximately 25 years. Indeed, that patent is so old, and the drug has such a proven track record for safety and efficacy, that the patent has expired and there are generic versions available. There is also in implicit assumption by the author that the only reason that the FDA will approve medications in a short time span is because they are for 'life-or-limb' or unmet serious medical need. This is just not the case - regulators in many countries, including the FDA in the USA, may give accelerated approval to a product, where the safety and tolerability of a product is equivalent to a similar active agent which has already been approved. I suspect this is the case for fluticasone fluroate - but I am not privy to the details of the regulatory filing. I note that none of the companies mentioned here, nor the FDA, has provided input to this article. The journalism in this article smacks of someone trying to make a name for themselves quickly by scaring uneducated and/or anxious people. The science is just plain flawed.
Pacificat April 12, 2013 at 12:49 pm
Please tell us in what ways it is ill-informed
Anon. April 11, 2013 at 08:22 pm
Ill-informed, sensationalist rubbish.
Deb Wong March 26, 2013 at 06:09 pm
Thanks, Stacie!
Stacie Chan (Editor) March 26, 2013 at 02:51 pm
Absolutely stunning photos, Deb! Thanks for sharing. I really feel like I was there by just perusingRead More your photo gallery.